Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 April 2024 | Story Anthony Mthembu | Photo Charl Devenish
Rea Parkies
Dr Reabetswe Parkies, Senior Officer in Marketing within the Faculty of Economic and Management Sciences at the University of the Free State (UFS), graduates with a PhD in Business Management at the April 2024 graduations.

The April 2024  graduations at the University of the Free State (UFS) mark a significant moment for graduates in the Faculty of Economic and Management Sciences (EMS),  including Dr Reabetswe Parkies, whose journey in attaining a PhD in Business Management has been one of dedication and perseverance.

Reflecting on the upcoming ceremony, Dr Parkies expressed mixed emotions, encapsulating the essence of her journey: ‘’As I prepare to walk across that stage, I'm filled with a mixture of emotions—excitement, pride, nostalgia, and perhaps a hint of apprehension about what lies ahead.’’ This moment represents the culmination of years of hard work and commitment to her academic pursuits.

Dr Parkies’s doctoral thesis, titled “Student self-employment in South Africa: A triple helix model, entrepreneurial competence and social support perspective,” delves into the complex dynamics of student entrepreneurship within the South African context. Her study aims to develop a comprehensive model for understanding self-employment, incorporating factors such as entrepreneurial competence, social support, and the role of the university, industry and government initiatives.

A culmination of years of hard work

The path to achieving her PhD was not without its challenges. Balancing her responsibilities as a Senior Officer in Marketing at the UFS with the demands of academic research required meticulous time management and personal sacrifice. ‘’As time went on, I found my rhythm and developed strategies to become more efficient and effective,’’ Dr Parkies explained. She credits her successful completion of the PhD to the unwavering support of her supervisors and her determination.

As she prepares to celebrate this milestone, Dr Parkies looks ahead to future contributions to her field. ’’By delving deeper into my area of expertise, I aim to uncover new insights and share these findings with the academic community through scholarly articles,’’ she remarked, emphasising her commitment to ongoing research and knowledge dissemination.

Dr Reabetswe Parkies's achievement serves as an inspiration to aspiring scholars and underscores the importance of perseverance and dedication in pursuing academic excellence. Her journey exemplifies the ethos of the University of the Free State in fostering academic growth and scholarly inquiry. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept